Filtros de búsqueda

Lista de obras de

A Parameter Estimation Method for Multiscale Models of Hepatitis C Virus Dynamics

artículo científico publicado en 2019

A Robust and Efficient Numerical Method for RNA-Mediated Viral Dynamics

artículo científico publicado en 2017

A mathematical model of hepatitis C virus dynamics in patients with high baseline viral loads or advanced liver disease

artículo científico publicado en 2009

A randomized, proof-of-concept clinical trial on repurposing chlorcyclizine for the treatment of chronic hepatitis C

artículo científico publicado en 2019

ANALYSIS OF HEPATITIS C VIRUS INFECTION MODELS WITH HEPATOCYTE HOMEOSTASIS

artículo científico publicado en 2009

Accounting for Space—Quantification of Cell-To-Cell Transmission Kinetics Using Virus Dynamics Models.

artículo científico publicado en 2018

Acute HBV infection in humanized chimeric mice has multiphasic viral kinetics

artículo científico publicado en 2018

Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C Infections

artículo científico publicado en 2015

Analysis of hepatitis C virus decline during treatment with the protease inhibitor danoprevir using a multiscale model

artículo científico publicado en 2013

Antiviral action of ribavirin in chronic hepatitis C.

artículo científico publicado en 2004

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication

artículo científico publicado en 2002

Correction: Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography

artículo científico publicado en 2019

Cure prevents more than transmission of hepatitis C virus

artículo científico publicado en 2016

Early HBV RNA kinetics under NA treatment may reveal new insights into HBV RNA dynamics and NA mode of action-more detailed kinetic studies are needed

artículo científico publicado en 2021

Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis

artículo científico publicado en 2018

Early Multiphasic HBV Infection Initiation Kinetics Is Not Clone-Specific and Is Not Affected by Hepatitis D Virus (HDV) Infection

artículo científico publicado en 2019

Early ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirin

artículo científico publicado en 2007

Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C.

artículo científico publicado en 2013

Efficient Methods for Parameter Estimation of Ordinary and Partial Differential Equation Models of Viral Hepatitis Kinetics

artículo científico publicado en 2020

End of treatment RNA-positive/sustained viral response in an individual with acute hepatitis C virus infection treated with direct-acting antivirals

artículo científico publicado en 2017

HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir.

artículo científico publicado en 2016

HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients

artículo científico publicado en 2017

HCVMultiscaleFit: A Simulator For Parameter Estimation in Multiscale Models Of Hepatitis C Virus Dynamics

scientific article published on 25 November 2020

Hepatitis B virus clearance rate estimates

artículo científico publicado en 2009

Hepatitis C Viral Kinetics in Special Populations

artículo científico publicado en 2008

Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B.

artículo científico publicado en 2011

Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128)

artículo científico publicado en 2012

Hepatitis C virus RNA kinetics: drug efficacy and the rate of HCV-infected cells loss

artículo científico publicado en 2007

Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report.

artículo científico publicado en 2016

Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees

artículo científico publicado en 2004

Hepatitis C virus kinetics in chimeric mice during antiviral therapy

artículo científico publicado en 2007

High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network Members

artículo científico publicado en 2017

How to eliminate HCV in people who inject drugs in the USA.

artículo científico publicado en 2017

Individualized treatment for patients with low HCV load (genotype 1): a viral kinetic approach

scientific article published on 14 April 2014

Letter to the Editor: Examining HBV RNA kinetics during NA treatment - are NA multifunctional antiviral agents?

artículo científico publicado en 2020

MULTI-OBJECTIVE MODEL EXPLORATION OF HEPATITIS C ELIMINATION IN AN AGENT-BASED MODEL OF PEOPLE WHO INJECT DRUGS

artículo científico publicado en 2019

Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago

artículo científico publicado en 2015

Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 Cells

artículo científico publicado en 2007

Mathematical modeling of HCV infection and treatment

artículo científico publicado en 2009

Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production

artículo científico publicado en 2005

Mathematical modeling of viral kinetics under immune control during primary HIV-1 infection

artículo científico publicado en 2009

Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins

artículo científico publicado en 2010

Modeling Challenges of Ebola Virus-Host Dynamics during Infection and Treatment

scientific article published on 16 January 2020

Modeling HCV cure after an ultra-short duration of therapy with direct acting agents

artículo científico publicado en 2017

Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon

artículo científico publicado en 2009

Modeling based response guided therapy in subjects with recent hepatitis C infection

artículo científico publicado en 2020

Modeling complex decay profiles of hepatitis B virus during antiviral therapy

artículo científico publicado en 2009

Modeling hepatitis C virus dynamics: Liver regeneration and critical drug efficacy

artículo científico publicado en 2007

Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago

scientific article published on 05 April 2019

Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users

article

Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life

artículo científico publicado en 2013

Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography

artículo científico publicado en 2019

Modeling suggests that virion production cycles within individual cells is key to understanding acute hepatitis B virus infection kinetics

artículo científico publicado en 2023

Modeling the acute and chronic phases of Theiler murine encephalomyelitis virus infection

artículo científico publicado en 2013

Modeling-based response-guided therapy for chronic hepatitis C under glecaprevir/pibrentasvir may identify patients for ultra-short treatment duration

scientific article published on 04 May 2020

Modelling hepatitis C virus kinetics: the relationship between the infected cell loss rate and the final slope of viral decay.

artículo científico publicado en 2009

Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg

artículo científico publicado en 2020

Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells.

artículo científico publicado en 2010

Numerical schemes for solving and optimizing multiscale models with age of hepatitis C virus dynamics.

artículo científico publicado en 2018

Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial.

artículo científico publicado en 2015

Pharmacodynamics of PEG-IFN-alpha-2a in HIV/HCV co-infected patients: implications for treatment outcomes

artículo científico publicado en 2010

Pharmacodynamics of PEG-IFN-α-2a and HCV Response as a Function of IL28B Polymorphism in HIV/HCV-Coinfected Patients ⬇️

artículo científico publicado el 1 de febrero de 2011

Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection

artículo científico publicado en 2017

Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin

scientific article published on 09 July 2019

Prevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapies

artículo científico publicado en 2016

Quantification of Hepatitis C Virus Cell-to-Cell Spread Using a Stochastic Modeling Approach

artículo científico publicado en 2015

Rapid emergence of protease inhibitor resistance in hepatitis C virus

artículo científico publicado en 2010

Reducing Sample Size While Improving Equity in Vaccine Clinical Trials: A Machine Learning-Based Recruitment Methodology with Application to Improving Trials of Hepatitis C Virus Vaccines in People Who Inject Drugs

artículo científico publicado en 2024

Reply: To PMID 25098971.

artículo científico publicado en 2015

Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study

artículo científico publicado en 2020

Resurrection of response-guided therapy for sofosbuvir combination therapies

artículo científico publicado en 2016

Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation.

artículo científico publicado en 2005

Severity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapy

artículo científico publicado en 2014

Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study

scientific article published on 06 May 2020

Silibinin mode(s) of action against hepatitis C virus: A controversy yet to be resolved ⬇️

artículo científico publicado el 27 de junio de 2011

Silymarin for HCV infection

artículo científico publicado en 2013

Stress-Induced Epstein-Barr Virus Reactivation

artículo científico publicado en 2021

Sustained virological response following an 11-day course of direct acting antiviral therapy for hepatitis C infection

artículo científico publicado en 2020

Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kinetics

artículo científico publicado en 2014

The extrahepatic contribution to HCV plasma viremia

artículo científico publicado en 2006

The hepatitis C virus NS5A inhibitor daclatasvir has a dual mode of action and leads to a new virus half-life estimate ⬇️

artículo científico publicado el 1 de julio de 2013

The rate of hepatitis C virus infection initiation in vitro is directly related to particle density.

artículo científico publicado en 2010

Thiazole antibiotics against breast cancer

artículo científico publicado en 2010

Treatment of hepatitis C with an interferon-based lead-in phase: a perspective from mathematical modelling

artículo científico publicado en 2014

Triphasic decline of hepatitis C virus RNA during antiviral therapy

artículo científico publicado en 2007

Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modeling

artículo científico publicado en 2014

Understanding silibinin’s modes of action against HCV using viral kinetic modeling ⬇️

artículo científico publicado el 13 de enero de 2012

Understanding the nature of early HCV RNA blips and the use of mathematical modeling of viral kinetics during IFN-based therapy

artículo científico publicado en 2011

Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling ⬇️

artículo científico publicado el 13 de diciembre de 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda